Current treatment patterns in non-melanoma skin cancer across Europe.
With marked increases in the annual incidence of non-melanoma skin cancer (NMSC) across the globe, its management is of increasing concern to dermatologists. This paper summarises the epidemiology and risk factors and provides an overview of treatment approaches in NMSC across Europe, including surgery, topical 5-fluorouracil and cryotherapy, in the context of the trade-offs that exist in finding optimal treatment outcomes. The paper will also briefly examine new approaches such as immunomodulators and the growing body of data on photodynamic therapy (PDT) using methyl aminolevulinate (MAL), including the authors' personal experience of the efficacy and cosmetic results obtained with these newer therapies.
Schmook
T
T
Department of Dermatology and Allergology, Charite Medical School Berlin Germany.
Stockfleth
E
E
D000279:Administration, Cutaneous; D000634:Aminoquinolines / Q000008:administration & dosage; D002280:Basal Cell Carcinoma / Q000473:pathology / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000628:therapy*; D017679:Cryotherapy; D003880:Dermatology; D005060:Europe; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D000077271:Imiquimod; D010778:Photochemotherapy; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*
D000634:Aminoquinolines; D000077271:Imiquimod; D005472:Fluorouracil